FILING ANALYSIS · THURSDAY, NOVEMBER 12

VOLITIONRX LTD VNRX — 8-K: Results of Operations and Financial Condition

neutral

The company reported a 157% increase in revenue to $1.6 million and a 14% decrease in operating expenses, with progress in commercializing its Nu.Q platform and strengthening its financial profile, but no significant quantified surprises to drive a large price move

The filing

8-K - VOLITIONRX LTD (0000093314) (Filer)

Read the filing on SEC EDGAR →

How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.

Get filings like this every market day

The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.

Subscribe free →
All analyses · Earnings today · Latest brief · Track record
© 2026 Dutchcode B.V. · Built by
Blinkof.ai verified — grade A+